VUMC

  • Vanderbilt University

    Vanderbilt basic science alum Q&A: Kate Mittendorf

    Kate Mittendorf, a graduate of the biochemistry department who is now a research assistant professor of medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center, sat down with us to discuss their experience studying basic science at Vanderbilt and how it played a role in their career. Read More

    Sep. 24, 2024

  • Vanderbilt University

    School of Medicine Basic Sciences Staff Spotlight: Stephen Doster

    Meet Stephen Doster, ‪associate program director of academic and educational support‬ in Basic Sciences. Read More

    May. 13, 2024

  • Vanderbilt University

    Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD

    Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79. Dr. Roberts, professor of Pharmacology and Medicine, emeritus, was perhaps best known… Read More

    Jun. 6, 2023

  • Vanderbilt University

    A new view of a cholesterol carrier

    High density lipoprotein (HDL) is often referred to as “good cholesterol.” However, cholesterol is just one of many types of cargo HDL can carry. In addition to shuttling cholesterol from blood to the liver, high-density lipoprotein (HDL) can also transport proteins, metabolites and small RNAs (sRNA). The discovery of HDL’s… Read More

    Feb. 10, 2023

  • Vanderbilt University

    Resistance to COVID-19 drug detected in lab study

    The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. The results of the laboratory study led by researchers at Vanderbilt University Medical Center and published April 28 in the journal Science… Read More

    May. 12, 2022

  • Vanderbilt University

    Resistance to COVID-19 drug detected in lab study

    The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. The results of the laboratory study led by researchers at Vanderbilt University Medical Center and published April 28 in the journal Science… Read More

    May. 12, 2022

  • Vanderbilt University

    Researchers find clue to drug-induced arrhythmias

    Researchers at Vanderbilt University Medical Center have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms. Their findings, reported recently in the journal Circulation, add significantly to understanding what causes abnormal heart rhythms, or arrhythmias, and… Read More

    Feb. 25, 2022

  • Vanderbilt University

    Pietenpol named chief scientific and strategy officer

    Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center (VICC), Benjamin F. Byrd Jr. Professor of Oncology and Executive Vice President for Research for Vanderbilt University Medical Center, is stepping down on June 30 from her long-held role as the Cancer Center’s director to focus on a combined leadership role… Read More

    Feb. 10, 2022